235 related articles for article (PubMed ID: 15022334)
1. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma.
Lambert NC; Erickson TD; Yan Z; Pang JM; Guthrie KA; Furst DE; Nelson JL
Arthritis Rheum; 2004 Mar; 50(3):906-14. PubMed ID: 15022334
[TBL] [Abstract][Full Text] [Related]
2. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset.
Rak JM; Pagni PP; Tiev K; Allanore Y; Farge D; Harlé JR; Launay D; Hachulla E; Didelot R; Cabane J; Kahan A; Martin M; Granel B; Roudier J; Lambert NC
Rheumatology (Oxford); 2009 Apr; 48(4):363-6. PubMed ID: 19208687
[TBL] [Abstract][Full Text] [Related]
3. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
[TBL] [Abstract][Full Text] [Related]
4. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block.
Stevens AM; Hermes HM; Lambert NC; Nelson JL; Meroni PL; Cimaz R
Rheumatology (Oxford); 2005 Feb; 44(2):187-91. PubMed ID: 15536065
[TBL] [Abstract][Full Text] [Related]
5. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens.
Artlett CM; Cox LA; Jimenez SA
Arthritis Rheum; 2000 May; 43(5):1062-7. PubMed ID: 10817560
[TBL] [Abstract][Full Text] [Related]
6. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis.
Johnson KL; Nelson JL; Furst DE; McSweeney PA; Roberts DJ; Zhen DK; Bianchi DW
Arthritis Rheum; 2001 Aug; 44(8):1848-54. PubMed ID: 11508438
[TBL] [Abstract][Full Text] [Related]
7. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
Sawaya HH; Jimenez SA; Artlett CM
Rheumatology (Oxford); 2004 Aug; 43(8):965-8. PubMed ID: 15199216
[TBL] [Abstract][Full Text] [Related]
8. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
9. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma.
Nelson JL; Furst DE; Maloney S; Gooley T; Evans PC; Smith A; Bean MA; Ober C; Bianchi DW
Lancet; 1998 Feb; 351(9102):559-62. PubMed ID: 9492775
[TBL] [Abstract][Full Text] [Related]
10. Feto-maternal microchimerism in connective tissue diseases.
Gannagé M; Amoura Z; Lantz O; Piette JC; Caillat-Zucman S
Eur J Immunol; 2002 Dec; 32(12):3405-13. PubMed ID: 12432571
[TBL] [Abstract][Full Text] [Related]
11. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma.
Evans PC; Lambert N; Maloney S; Furst DE; Moore JM; Nelson JL
Blood; 1999 Mar; 93(6):2033-7. PubMed ID: 10068676
[TBL] [Abstract][Full Text] [Related]
12. [Microchimerisme in systemic sclerosis].
Aractingi S; Regnier S
Ann Med Interne (Paris); 2002 May; 153(3):189-91. PubMed ID: 12218902
[TBL] [Abstract][Full Text] [Related]
13. Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages and NK cells.
Loubière LS; Lambert NC; Flinn LJ; Erickson TD; Yan Z; Guthrie KA; Vickers KT; Nelson JL
Lab Invest; 2006 Nov; 86(11):1185-92. PubMed ID: 16969370
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma.
Reed W; Kong DZ; Lee TH; Cowan MJ; Busch MP; Baxter-Lowe LA
Bone Marrow Transplant; 2002 Mar; 29(6):527-9. PubMed ID: 11960275
[TBL] [Abstract][Full Text] [Related]
15. [Immunogenetic studies of familial occurrence of progressive systemic scleroderma and circumscribed scleroderma].
Holzmann H; Schlieter A; Altmeyer P; Kühnl P
Hautarzt; 1992 Sep; 43(9):548-53. PubMed ID: 1399599
[TBL] [Abstract][Full Text] [Related]
16. Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma.
Di Cristofaro J; Karlmark KR; Kanaan SB; Azzouz DF; El Haddad M; Hubert L; Farge-Bancel D; Granel B; Harlé JR; Hachulla E; Pardoux E; Roudier J; Picard C; Lambert NC
Front Immunol; 2018; 9():1685. PubMed ID: 30158921
[TBL] [Abstract][Full Text] [Related]
17. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son.
Lambert NC; Pang JM; Yan Z; Erickson TD; Stevens AM; Furst DE; Nelson JL
Ann Rheum Dis; 2005 Jun; 64(6):845-8. PubMed ID: 15550532
[TBL] [Abstract][Full Text] [Related]
18. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea.
Joung CI; Jun JB; Chung WT; Song GG; Choe JY; Chang HK; Yoo DH
Scand J Rheumatol; 2006; 35(1):39-43. PubMed ID: 16467040
[TBL] [Abstract][Full Text] [Related]
19. PCR-based methodology for molecular microchimerism detection and quantification.
Pujal JM; Gallardo D
Exp Biol Med (Maywood); 2008 Sep; 233(9):1161-70. PubMed ID: 18535170
[TBL] [Abstract][Full Text] [Related]
20. Persisting fetal microchimerism does not interfere with forensic Y-chromosome typing.
Klintschar M; Schwaiger P; Regauer S; Mannweiler S; Kleiber M
Forensic Sci Int; 2004 Jan; 139(2-3):151-4. PubMed ID: 15040908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
